U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07655505) titled 'Use of Force Feedback Instruments With the da Vinci Surgical System, Model IS5000 for Mitra... Read More
U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07655700) titled 'Comparison of Propranolol, Flunarizine and Their Combination in Preventing Migraine in Adul... Read More
U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657910) titled 'Evaluation of Occlusal Contact Distribution in Digitally Fabricated Implant-Retained Fixed ... Read More
U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07657884) titled 'Assessment of the Usefulness of SMI (Superb Vascular Imaging) for the Characterisation of P... Read More
Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pha... Read More
Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled Phase 2 study to investigate the effic... Read More
Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More